Skip to main content
Log in

Haplotype analysis of CLDN19 single nucleotide polymorphisms in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis

  • Brief report
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Background

Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is an autosomal recessive tubular disease caused by mutations in the CLDN16 or CLDN19 gene. Previous studies using microsatellite markers flanking the CLDN19 locus estimated that p.G20D (c.59G>A), a recurrent mutation in Spanish families, is a founder mutation. In the present study, we assessed the haplotype of Spanish patients using single nucleotide polymorphisms (SNPs).

Methods

Twenty-seven FHHNC patients were included in this study. We analyzed four SNPs located in CLDN19 introns 3 and 4 by polymerase chain reaction amplification and DNA sequencing.

Results

Three new patients with homozygous p.G20D were identified. The SNP genotyping analysis showed that alleles carrying this mutation shared a common SNP haplotype.

Conclusions

Our findings suggest the existence of a founder effect responsible for FHHNC in our cohort. Testing for the presence of mutation p.G20D should be the first genetic screening in Spanish patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Praga M, Vara J, González-Parra E, Andrés A, Alamo C, Araque A, et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 1995;47:1419–1425.

    Article  CAS  PubMed  Google Scholar 

  2. Knoers NV. Inherited forms of renal hypomagnesemia: an update. Pediatr Nephrol 2009;24:697–705.

    Article  PubMed  Google Scholar 

  3. Rodríguez-Soriano J, Vallo A, García-Fuentes M. Hypomagnesaemia of hereditary renal origin. Pediatr Nephrol 1987;1:465–472.

    Article  PubMed  Google Scholar 

  4. Benigno V, Canonica CS, Bettinelli A, von Vigier RO, Truttmann AC, Bianchetti MG. Hypomagnesaemia-hypercalciurianephrocalcinosis: a report of nine cases and a review. Nephrol Dial Transplant 2000;15:605–610.

    Article  CAS  PubMed  Google Scholar 

  5. Weber S, Schneider L, Peters M, Misselwitz J, Rönnefarth G, Böswald M, et al. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 2001;12:1872–1881.

    CAS  PubMed  Google Scholar 

  6. Blanchard A, Jeunemaitre X, Coudol P, Dechaux M, Froissart M, May A, et al. Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 2001;59:2206–2015.

    Article  CAS  PubMed  Google Scholar 

  7. Konrad M, Schaller A, Seelow D, Pandey AV, Waldegger S, Lesslauer A, et al. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 2006;79:949–957.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 1999;285:103–106.

    Article  CAS  PubMed  Google Scholar 

  9. Faguer S, Chauveau D, Cintas P, Tack I, Cointault O, Rostaing L, et al. Renal, ocular, and neuromuscular involvements in patients with CLDN19 mutations. Clin J Am Soc Nephrol 2011;6:355–360.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Godron A, Harambat J, Boccio V, Mensire A, May A, Rigothier C, et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations. Clin J Am Soc Nephrol 2012;7:801–809.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Claverie-Martín F, García-Nieto V, Loris C, Ariceta G, Nadal I, Espinosa L, et al. Claudin-19 mutations and clinical phenotype in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. PLoS One 2013;8: 53151.

    Article  Google Scholar 

  12. Hou J, Renigunta A, Konrad M, Gomes AS, Schneeberger EE, Paul DL, et al. Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest 2008;118:619–628.

    CAS  PubMed Central  PubMed  Google Scholar 

  13. Hou J, Rajagopal M, Yu AS. Claudins and the kidney. Annu Rev Physiol 2013;75:479–501.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Hou J, Renigunta A, Gomes AS, Hou M, Paul DL, Waldegger S, et al. Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc Natl Acad Sci U S A 2009;106:15350–15355.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Müller D, Kausalya PJ, Claverie-Martin F, Meij IC, Eggert P, Garcia-Nieto V, et al. A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting. Am J Hum Genet 2003;73:1293–1301.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Felix Claverie-Martin.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martin-Nuñez, E., Cordoba-Lanus, E., Gonzalez-Acosta, H. et al. Haplotype analysis of CLDN19 single nucleotide polymorphisms in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. World J Pediatr 11, 272–275 (2015). https://doi.org/10.1007/s12519-014-0528-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-014-0528-3

Key words

Navigation